rivastigmine has been researched along with clioquinol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Li, Q; Liang, M; Shen, Z; Tang, L; Wang, B; Wang, Q; Zhang, C; Zhang, Z; Zheng, X | 1 |
1 other study(ies) available for rivastigmine and clioquinol
| Article | Year |
|---|---|
Development of the "hidden" multifunctional agents for Alzheimer's disease.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Chelating Agents; Cholinesterase Inhibitors; Drug Design; ERG1 Potassium Channel; Male; Mice; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Nootropic Agents; Peptide Fragments; Protein Multimerization; Quinolines; Rats, Sprague-Dawley; Structure-Activity Relationship; Zebrafish | 2019 |